The efficacy and safety of AvaultaTM for surgical treatment of advanced pelvic organ prolapse

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-ONC-12002785

Enrollment

Unknown

Registered

2012-11-17

Start date

2012-06-20

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pelvic organ prolapse

Interventions

1:Avaulta operation

Eligibility

Sex/Gender

Female

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All patiAll patients who underwent surgery with the Avaulta synthetic mesh kit

Exclusion criteria

Exclusion criteria: Unable to give informed consent to participate

Design outcomes

Primary

Measure	Time frame
pelvic organ prolapse quantitation, POP-Q;Operative complication;	—

Secondary

Measure	Time frame
pelvic floor distress inventory-short form 20, PFDI-20;pelvic floor impact questionnaire-short form 7, PFIQ-7;Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12);	—

Countries

China

Contacts

Public ContactSong Yanfeng

zlele@126.com+86 13905909403

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026